Dialysis industry news

Stories from the dialysis comunity across the globe.



U.S. Dialysis Patients Increasingly Live in Poor Areas - Philly.com PDF Print
Posted: Wednesday, June 24, 2015, 12:00 PM

image

WEDNESDAY, June 24, 2015 (HealthDay News) -- More than one-third of kidney dialysis patients in the United States live in poor neighborhoods, a study finds.

Kidney dialysis rates in the United States are higher in poor neighborhoods, and they're increasing in those areas, the 15-year analysis shows. Dialysis is used to treat people with kidney failure.

Researchers analyzed U.S. Centers for Medicare and Medicaid Services data to assess overall dialysis rates and those in poor areas, defined as having a a zip code where at least 20 percent of people live below the federal poverty line.

The results showed that 27.4 percent of adults who began dialysis between 1995 and 2004 lived in poor neighborhoods, compared with about 11 percent of adults in the general population.

Those percentages increased to 34 percent and 12.5 percent, respectively, between 2005 and 2010, said the researchers from Loyola University Chicago Stritch School of Medicine.

The study was published recently in the journal Hemodialysis International.

The researchers said it's not clear why kidney failure and dialysis rates are higher in poor neighborhoods. Possible reasons could be less access to health care, greater exposure to environmental toxins and lifestyle habits, they said.

Future studies of kidney failure rates should examine long-term trends in poverty at the individual level and in smaller geographic areas, said corresponding author Dr. Holly Kramer and colleagues.

"The collection of such data may help track national and local trends in poverty status and be used to develop policies for improving health outcomes and disease prevention," they wrote.

More information

The National Kidney Foundation has more about dialysis.


-- Robert Preidt

SOURCE: Loyola University Health System, June 16, 2015

Copyright © 2015 HealthDay. All rights reserved.

...

 
Unused dialysis machines lying at Sion hospital; lack of staff, space - Hindustan Times PDF Print

Sion Hospital, one of largest tertiary care centres in Mumbai is struggling to treat patients with just one dialysis machine even though 12 new dialysis machines are lying unpacked for over six months due to space and staff shortage. 

“Even if the 12 new machines were to be installed, the hospital does not have technicians to operate the machines and carry out dialysis round the clock,” said a member of the hospital staff. The hospital reportedly had three technicians but as of now only one of them has been on duty.

According to the hospital, the Acute Kidney Diseases Unit (AKD)  unit was due to be shifted into the newly constructed outdoor patient building  which has caused the delay in the installation of the machines has been because of infrastructural issues. “The installation and the public works department (PWD) work started from KEM and Nair Hospitals and then it was Sion Hospital’s turn. Once the PWD work is taken care of we’d be able to start the dialysis facilities,” said Dr N Moulick, head of department of medicine and in-charge of AKD unit.

Patients are being either turned away and some have been skipping dialysis schedules because of the lack of enough machines.

The dean of the hospital however had assured that the AKD unit would be functional by the June 25 but as on Monday the machines were not yet installed.

...

 
Growth Stock Watch: NxStage Medical, Inc. (NASDAQ:NXTM) - Enterprise Leader PDF Print

NxStage Medical, Inc. (NASDAQ:NXTM) has been given a positive Growth Style Score by Zacks Research. The Growth score analyzes the growth prospects for a company in addition to analyzing company financials. The score takes into account various measures of the Income Statement, Cash Flow Statement and Balance Sheet to achieve a ranking of A-F, where A indicates that the stock has the best growth characteristics likely to outperform the market.

Analysts tracked by Zacks have given NxStage Medical, Inc. a mean long term growth estimate of 18.33. This number is based on sales and earnings over the next 3-5 years, calculated on a consensus basis. On a shorter term basis, analysts have a projected price target of $21 on the equity. This is a one-year consensus target based on 4 sell-side analysts providing estimates. The firm with the most bullish sentiment sees the stock reaching $24 while the most conservative has the target set at $15. Sell-side firms use a variety of different terms such a Buy, Sell and Hold to rate their outlook on stocks. Using a simplified scale where Strong Buy equals 1 and Strong Sell equals 5, the consensus simplified rating for NxStage Medical, Inc. is 2. NxStage Medical, Inc. (NASDAQ:NXTM) is next slated to report quarterly results on 2015-08-06 where the Street is anticipating earnings per share of $-0.1. Most recently the firm reported earnings of $0 for the period ending on 2015-03-31. NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company’s primary product is the NxStage System One (System One). It also sells needles and blood tubing sets primarily to dialysis clinics for the treatment of end-stage renal disease (ESRD). It operates in two segments: System One and In-Center. It distributes its products in three markets: home, critical care and in-center. In the System One segment it derives its revenues from the sale and rental of the System One and PureFlow SL equipment, and the sale of disposable products in the home and critical care markets. In the In-Center segment, it derives its revenues from the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis, which is referred to as the in-center market.

...

 
US Dialysis Patients Increasingly Live in Poor Areas - U.S. News World Report PDF Print
<![CDATA[.cms-textAlign-left{text-align:left;}.cms-textAlign-center{text-align:center;}.cms-textAlign-right{text-align:right;}.cms-custom-quote{border-left: 1px solid #eee; margin-left: 15px; padding-left: 15px; font-style: italic; font-size: 17px; line-height: 28px; color: #666;}]]>

By Robert Preidt, HealthDay Reporter

WEDNESDAY, June 24, 2015 (HealthDay News) -- More than one-third of kidney dialysis patients in the United States live in poor neighborhoods, a study finds.

Kidney dialysis rates in the United States are higher in poor neighborhoods, and they're increasing in those areas, the 15-year analysis shows. Dialysis is used to treat people with kidney failure.

Researchers analyzed U.S. Centers for Medicare and Medicaid Services data to assess overall dialysis rates and those in poor areas, defined as having a a zip code where at least 20 percent of people live below the federal poverty line.

The results showed that 27.4 percent of adults who began dialysis between 1995 and 2004 lived in poor neighborhoods, compared with about 11 percent of adults in the general population.

Those percentages increased to 34 percent and 12.5 percent, respectively, between 2005 and 2010, said the researchers from Loyola University Chicago Stritch School of Medicine.

The study was published recently in the journal Hemodialysis International.

The researchers said it's not clear why kidney failure and dialysis rates are higher in poor neighborhoods. Possible reasons could be less access to health care, greater exposure to environmental toxins and lifestyle habits, they said.

Future studies of kidney failure rates should examine long-term trends in poverty at the individual level and in smaller geographic areas, said corresponding author Dr. Holly Kramer and colleagues.

"The collection of such data may help track national and local trends in poverty status and be used to develop policies for improving health outcomes and disease prevention," they wrote.

More information

The National Kidney Foundation has more about dialysis.

Copyright © 2015 HealthDay. All rights reserved.

...

 
Hold Smartphones Away from Cardiac Devices - Renal and Urology News PDF Print
June 24, 2015 Hold Smartphones Away from Cardiac Devices - Renal and Urology News
Risk is low; however, heart patients are advised to keep phones away from chest pockets.

(HealthDay News) -- Smartphones should be kept a safe distance from implanted cardiac devices like pacemakers and defibrillators, in the rare chance that signaling interference occurs, according to new research. The findings were scheduled to be presented Monday at the joint meeting of the European Heart Rhythm Association of the European Society of Cardiology and Cardiostim in Milan.

Researchers tracked the effects of smartphones on 308 patients with an implanted cardiac device. Participants were exposed to the electromagnetic field of 3 common smartphones: the Samsung Galaxy 3; Nokia Lumia; and HTC One XL. These phones were placed on the patients' skin directly above their heart device. After being connected to a radio communication tester that functions like a mobile network station, the researchers analyzed how activities such as connecting calls, ringing, talking, and hanging up all affected the cardiac devices. Electrocardiograms recorded continuously.

After conducting more than 3,400 tests on EMI, the researchers found that only 1 of the patients was affected by interference caused by smartphones. This person had a magnetic resonance imaging-compatible implanted defibrillator, which misinterpreted electromagnetic waves from the Nokia and HTC smartphones. The new findings suggest that interference between smartphones and cardiac devices is uncommon; however, it "can occur, so the current recommendations on keeping a safe distance should be upheld." lead author Carsten Lennerz, M.D., a cardiology resident at the German Heart Centre in Munich, said in a news release from the European Society of Cardiology.

"Nearly everyone uses smartphones and there is the possibility of interference with a cardiac device if you come too close," senior author Christof Kolb, M.D., prior head of electrophysiology at the German Heart Centre, said in the news release. "Patients with a cardiac device can use a smartphone," Kolb said. "But they should not place it directly over the cardiac device. That means not storing it in a pocket above the cardiac device. They should also hold their smartphone to the ear opposite to the side of the device implant."

Source

  1. European Society of Cardiology News Release, June 22, 2015

...

 
<< Start < Prev 141 142 143 144 145 146 147 148 149 150 Next > End >>

Page 141 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.